DOCSLIB.ORG

Identification of Key Genes and Mirnas Markers of Papillary Thyroid

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Identification of Key Genes and Mirnas Markers of Papillary Thyroid Qiu et al. Biol Res (2018) 51:45 https://doi.org/10.1186/s40659-018-0188-1 Biological Research RESEARCH ARTICLE Open Access Identifcation of key genes and miRNAs markers of papillary thyroid cancer Jie Qiu1†, Wenwei Zhang2†, Chuanshan Zang1, Xiaomin Liu1, Fuxue Liu3, Ruifeng Ge1, Yan Sun1* and Qingsheng Xia4* Abstract Objective: In this study, crucial genes and microRNAs (miRNAs) associated with the progression, staging, and prog- nosis of papillary thyroid cancer (PTC) were identifed. Methods: Four PTC datasets, including our own mRNA-sequencing (mRNA-seq) dataset and three public datasets downloaded from Gene Expression Omnibus and The Cancer Genome Atlas, were used to analyze diferentially expressed genes (DEGs) and miRNAs (DEMs) between PTC tumor tissues and paired normal tissues (control). Gene ontology (GO) terms and pathways associated with these DEGs were identifed, and protein–protein interactions (PPIs) were analyzed. Additionally, an miRNA-mRNA regulatory network was constructed and the functions of DEMs were explored. Finally, miRNAs/mRNAs associated with tumor staging and prognosis were identifed. The expression levels of several key genes and miRNAs were validated by qRT-PCR. Results: Numerous DEGs and DEMs were identifed between tumor and control groups in four datasets. The DEGs were signifcantly enriched in cell adhesion and cancer-related GO terms and pathways. In the constructed PPI network, ITGA2, FN1, ICAM1, TIMP1 and CDH2 were hub proteins. In the miRNA-mRNA negative regulatory networks, miR-204-5p regulated the largest number of target genes, such as TNFRSF12A. miR-146b, miR-204, miR-7-2, and FN1 were associated with tumor stage in PTC, and TNFRSF12A and CLDN1 were related to prognosis. Conclusions: Our results suggested the important roles of ITGA2, FN1, ICAM1, TIMP1 and CDH2 in the progression of PTC. miR-204-5p, miR-7-2, and miR-146b are potential biomarkers for PTC staging and FN1, CLDN1, and TNFRSF12A may serve as markers of prognosis in PTC. Keywords: Papillary thyroid cancer, Gene, miRNA, Tumor stage, Prognosis Background common, accounting for 75–85% of all thyroid cancer Tyroid cancer is the most common endocrine neo- cases [3]. PTC is usually curable and has a 5-year survival plasm, accounting for approximately 1.7% of all human rate of over 95% [4]. However, PTC occasionally dedifer- malignancies [1]. Tyroid cancer is usually classifed into entiates into more aggressive and lethal thyroid cancers. four types: papillary thyroid cancer (PTC), anaplastic thy- Additionally, recurrences are observed in approximately roid cancer, follicular thyroid cancer, and medullary thy- 30% of patients with PTC. Terefore, further analyses of roid cancer [2]. Among the four types, PTC is the most the molecular characteristics of this disease are necessary [5]. Genetic mutations have been identifed in the major- *Correspondence: [email protected]; [email protected] ity of PTC cases and are believed to be responsible for †Jie Qiu and Wenwei Zhang are co-frst authors PTC initiation [6]. A high frequency of activating somatic 1 Otolaryngology Head and Neck Surgery, The Afliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao 266071, Shandong alterations in genes encoding efectors in the MAPK Province, China (mitogen-activated protein kinase) signaling pathway, 4 Otolaryngology Head and Neck Surgery, Qingdao Municipal Hospital, such as BRAF, RAS, and RET, has been found in PTC [7– No. 5 Donghai Road, Qingdao 266071, Shandong, China Full list of author information is available at the end of the article 9]; these mutations act as drivers in approximately 70% © The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creat​iveco​mmons​.org/licen​ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat​iveco​mmons​.org/ publi​cdoma​in/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Qiu et al. Biol Res (2018) 51:45 Page 2 of 11 of PTC cases [10]. Additionally, galectin-3 (LGALS3), Table 1 Characteristics of patients platelet-derived growth factor (PDGF), and epithelial Samples Hospitalization Sex Age TNM stage Clinical stage muctin-1 (MUC-1) are also potential biomarkers of PTC starting time [11, 12]. A recent study has demonstrated that numerous P1/N1 2014/7/31 Male 26 T1N1aM0 I microRNAs (miRNAs) are transcriptionally up-regulated P2/N2 2014/8/13 Male 43 T1N1aM0 I in PTC compared with normal tissues [13]. miR-181b, P3/N3 2014/8/11 Female 47 T1N1aM0 III miR-221, and miR-222 have been suggested to be overex- P4/N4 2014/8/11 Male 25 T1N1aM0 I pressed in most thyroid tissues originating from patients P5/N5 2014/8/12 Female 46 T1N1aM0 III afected by PTC [14]. Although numerous molecular P6/N6 2017/7/27 Female 45 T1N1aM0 I markers associated with the carcinogenesis of PTC have P7/N7 2017/7/27 Female 61 T1N1aM0 I been identifed, signifcant uncertainty remains regarding P8/N8 2017/8/1 Male 55 T1N1aM0 I its molecular mechanisms. Furthermore, prognosis- or P9N9 2017/8/16 Female 50 T1N1aM0 I staging-related molecular targets need to be explored. P10/N10 2017/8/17 Female 45 T1N1aM0 I Microarrays have made it possible to analyze genome- P11/N11 2017/8/17 Female 66 T1N1aM0 I wide miRNA or mRNA expression [15]. In this study, P12/N12 2017/9/14 Male 33 T1N1aM0 I we combined our mRNA-sequencing (mRNA-seq) data P13N13 2017/9/14 Female 47 T1N1aM0 I with three public datasets (miRNA-seq and mRNA-seq) P14/N14 2017/9/18 Female 54 T1N1aM0 I downloaded from Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and Te Cancer P papillary thyroid carcinoma, N paired adjacent normal tissues, TNM tumor- node-metastasis Genome Atlas (TCGA, https ://tcga-data.nci.nih.gov/) to analyze diferentially expressed genes (DEGs) and miR- NAs (DEMs) between PTC tumor tissues and normal Illumina HiSeq2000 platform (Illumina, San Diego, CA, tissue samples (control). Common miRNAs and mRNAs USA). After sequencing, RNA-seq data were preproc- between our mRNA-seq dataset and public datasets essed, including the removal of the adaptor sequence were selected for subsequent analyses, including analy- from raw reads and the fltering of reads with a high N ses of gene ontology (GO) biological processes, pathway content and low quality. Te detailed sequencing and enrichment, and protein–protein interactions (PPIs), the preprocessing procedures are described in our previous construction of miRNA-mRNA regulatory networks, as study [16]. well as the identifcation of miRNAs and mRNAs asso- ciated with staging and prognosis. Moreover, the expres- Public data collection sion levels of several key mRNAs and miRNAs identifed miRNA microarray data (accession GSE57780) were in these analyses were confrmed by qRT-PCR. Loci iden- downloaded from the GEO database. A total of 9 samples tifed in this study may act as important therapeutic tar- were available, i.e., 3 PTC tissues, 3 normal tissues, and 3 gets or prognostic markers in PTC. nodal metastases. In this study, 3 PTC and 3 normal tis- sues were selected for further analysis. Te platform used Methods to obtain these data was the Illumina HiSeq2000. Tissue samples and mRNA‑seq data collection Additionally, PTC-associated mRNA-seq, miRNA-seq, Five PTC tumor samples (P1–P5) and paired peritu- and clinical data were downloaded from TCGA using moral thyroid tissue samples as controls (N1–N5) were the TCGAbiolinks R package. In total, 552 samples were obtained from patients with PTC who underwent thy- included. roidectomy. Te tumor samples and paired peritumoral thyroid tissue samples were obtained by thyroidectomy Diferential expression analysis and stored in RNA store Reagent DP408-02 (Tiangen Using our own mRNA-seq data, gene expression levels Biotech Co., Ltd., Beijing, China) at 4 °C in a refrigera- were calculated using the RPKM method. DEGs between tor. Tumor stages were determined based on the tumor- the PTC and control groups were detected using the node-metastasis (TNM) criteria. Detailed patient edgeR [17] tool (version 3.4, http://www.bioco nduct information is provided in Table 1. Informed consent was or.org/packa ges/relea se/bioc/html/edgeR .html), and the obtained from all patients. Tis study was approved by signifcance of DEGs was calculated based on the nega- the local Research Ethics Committee. tive binomial model. Te obtained P-values were adjusted After tissue collection, total RNAs were extracted using using the Benjamini and Hochberg method [5] to obtain the RNAprep Pure Tissue Kit (Tiangen Biotech Co., Ltd.) the false discovery rate (FDR). Te thresholds for DEG according to the manufacturer’s protocol and was then selection were FDR < 0.05 and |log2 fold change (FC)| > 2. converted to Tru-Seq libraries for sequencing using the Qiu et al. Biol Res (2018) 51:45 Page 3 of 11 Te mRNA-seq and miRNA-seq data obtained from to construct the miRNA-mRNA negative regulatory net- TCGA and GEO were also preprocessed using edgeR work. Te key miRNAs and genes were identifed based [17] (version 3.4) in R. Te raw counts were converted on a network topological property analysis. to log2-counts-per-million (logCPM) followed by linear modeling and the mean–variance relationship was mod- miRNA function analysis eled with precision weights using the voom [18] method For genes involved in the miRNA-mRNA negative reg- in limma. Te diferential expression analysis (tumor ulatory network, GO and KEGG pathway enrichment vs. control) was performed using t-tests implemented analyses were performed using clusterProfler [26] in R.
Load more

Recommended publications
  • Human N-Cadherin / CD325 / CDH2 Protein (His & Fc Tag)
    Human N-Cadherin / CD325 / CDH2 Protein (His & Fc Tag) Catalog Number: 11039-H03H General Information SDS-PAGE: Gene Name Synonym: CD325; CDHN; CDw325; NCAD Protein Construction: A DNA sequence encoding the human CDH2 (NP_001783.2) (Met 1-Ala 724) was fused with the C-terminal polyhistidine-tagged Fc region of human IgG1 at the C-terminus. Source: Human Expression Host: HEK293 Cells QC Testing Purity: > 70 % as determined by SDS-PAGE Endotoxin: Protein Description < 1.0 EU per μg of the protein as determined by the LAL method Cadherins are calcium dependent cell adhesion proteins, and they preferentially interact with themselves in a homophilic manner in Stability: connecting cells. Cadherin 2 (CDH2), also known as N-Cadherin (neuronal) (NCAD), is a single-pass tranmembrane protein and a cadherin containing ℃ Samples are stable for up to twelve months from date of receipt at -70 5 cadherin domains. N-Cadherin displays a ubiquitous expression pattern but with different expression levels between endocrine cell types. CDH2 Asp 160 Predicted N terminal: (NCAD) has been shown to play an essential role in normal neuronal Molecular Mass: development, which is implicated in an array of processes including neuronal differentiation and migration, and axon growth and fasciculation. The secreted recombinant human CDH2 is a disulfide-linked homodimeric In addition, N-Cadherin expression was upregulated in human HSC during protein. The reduced monomer comprises 813 amino acids and has a activation in culture, and function or expression blocking of N-Cadherin predicted molecular mass of 89.9 kDa. As a result of glycosylation, it promoted apoptosis. During apoptosis, N-Cadherin was cleaved into 20- migrates as an approximately 114 and 119 kDa band in SDS-PAGE under 100 kDa fragments.
    [Show full text]
  • The N-Cadherin Interactome in Primary Cardiomyocytes As Defined Using Quantitative Proximity Proteomics Yang Li1,*, Chelsea D
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs221606. doi:10.1242/jcs.221606 TOOLS AND RESOURCES The N-cadherin interactome in primary cardiomyocytes as defined using quantitative proximity proteomics Yang Li1,*, Chelsea D. Merkel1,*, Xuemei Zeng2, Jonathon A. Heier1, Pamela S. Cantrell2, Mai Sun2, Donna B. Stolz1, Simon C. Watkins1, Nathan A. Yates1,2,3 and Adam V. Kwiatkowski1,‡ ABSTRACT requires multiple adhesion, cytoskeletal and signaling proteins, The junctional complexes that couple cardiomyocytes must transmit and mutations in these proteins can cause cardiomyopathies (Ehler, the mechanical forces of contraction while maintaining adhesive 2018). However, the molecular composition of ICD junctional homeostasis. The adherens junction (AJ) connects the actomyosin complexes remains poorly defined. – networks of neighboring cardiomyocytes and is required for proper The core of the AJ is the cadherin catenin complex (Halbleib and heart function. Yet little is known about the molecular composition of the Nelson, 2006; Ratheesh and Yap, 2012). Classical cadherins are cardiomyocyte AJ or how it is organized to function under mechanical single-pass transmembrane proteins with an extracellular domain that load. Here, we define the architecture, dynamics and proteome of mediates calcium-dependent homotypic interactions. The adhesive the cardiomyocyte AJ. Mouse neonatal cardiomyocytes assemble properties of classical cadherins are driven by the recruitment of stable AJs along intercellular contacts with organizational and cytosolic catenin proteins to the cadherin tail, with p120-catenin β structural hallmarks similar to mature contacts. We combine (CTNND1) binding to the juxta-membrane domain and -catenin β quantitative mass spectrometry with proximity labeling to identify the (CTNNB1) binding to the distal part of the tail.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • And MUC1 in Mammary Epithelial Cells
    Linköping University Post Print Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells Stina Petersson, E. Shubbar, M. Yhr, A. Kovacs and Charlotta Enerbäck N.B.: When citing this work, cite the original article. The original publication is available at www.springerlink.com: Stina Petersson, E. Shubbar, M. Yhr, A. Kovacs and Charlotta Enerbäck, Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells, 2011, Breast Cancer Research and Treatment, (125), 1, 13-25. http://dx.doi.org/10.1007/s10549-010-0820-4 Copyright: Springer Science Business Media http://www.springerlink.com/ Postprint available at: Linköping University Electronic Press http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-63954 1 Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells Petersson S1, Shubbar E1, Yhr M1, Kovacs A2 and Enerbäck C3 Departments of 1Clinical Genetics and 2Pathology, Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden; 3Department of Clinical and Experimental Medicine, Division of Cell Biology and Dermatology, Linköping University, SE-581 85 Linköping, Sweden E-mail: [email protected] E-mail: maria.yhr@ clingen.gu.se E-mail: [email protected] E-mail: [email protected] Correspondence: Stina Petersson, Department of Clinical Genetics, Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden E-mail: [email protected] 2 Abstract Psoriasin (S100A7), a member of the S100 gene family, is highly expressed in high-grade comedo ductal carcinoma in situ (DCIS), with a higher risk of local recurrence. Psoriasin is therefore a potential biomarker for DCIS with a poor prognosis.
    [Show full text]
  • Cell Adhesion Molecules in Normal Skin and Melanoma
    biomolecules Review Cell Adhesion Molecules in Normal Skin and Melanoma Cian D’Arcy and Christina Kiel * Systems Biology Ireland & UCD Charles Institute of Dermatology, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +353-1-716-6344 Abstract: Cell adhesion molecules (CAMs) of the cadherin, integrin, immunoglobulin, and selectin protein families are indispensable for the formation and maintenance of multicellular tissues, espe- cially epithelia. In the epidermis, they are involved in cell–cell contacts and in cellular interactions with the extracellular matrix (ECM), thereby contributing to the structural integrity and barrier for- mation of the skin. Bulk and single cell RNA sequencing data show that >170 CAMs are expressed in the healthy human skin, with high expression levels in melanocytes, keratinocytes, endothelial, and smooth muscle cells. Alterations in expression levels of CAMs are involved in melanoma propagation, interaction with the microenvironment, and metastasis. Recent mechanistic analyses together with protein and gene expression data provide a better picture of the role of CAMs in the context of skin physiology and melanoma. Here, we review progress in the field and discuss molecular mechanisms in light of gene expression profiles, including recent single cell RNA expression information. We highlight key adhesion molecules in melanoma, which can guide the identification of pathways and Citation: D’Arcy, C.; Kiel, C. Cell strategies for novel anti-melanoma therapies. Adhesion Molecules in Normal Skin and Melanoma. Biomolecules 2021, 11, Keywords: cadherins; GTEx consortium; Human Protein Atlas; integrins; melanocytes; single cell 1213. https://doi.org/10.3390/ RNA sequencing; selectins; tumour microenvironment biom11081213 Academic Editor: Sang-Han Lee 1.
    [Show full text]
  • CDH2 and CDH11 Act As Regulators of Stem Cell Fate Decisions Stella Alimperti A, Stelios T
    Stem Cell Research (2015) 14, 270–282 Available online at www.sciencedirect.com ScienceDirect www.elsevier.com/locate/scr REVIEW CDH2 and CDH11 act as regulators of stem cell fate decisions Stella Alimperti a, Stelios T. Andreadis a,b,⁎ a Bioengineering Laboratory, Department of Chemical and Biological Engineering, University at Buffalo, State University of New York, Amherst, NY 14260-4200, USA b Center of Excellence in Bioinformatics and Life Sciences, Buffalo, NY 14203, USA Received 18 September 2014; received in revised form 24 January 2015; accepted 10 February 2015 Abstract Accumulating evidence suggests that the mechanical and biochemical signals originating from cell–cell adhesion are critical for stem cell lineage specification. In this review, we focus on the role of cadherin mediated signaling in development and stem cell differentiation, with emphasis on two well-known cadherins, cadherin-2 (CDH2) (N-cadherin) and cadherin-11 (CDH11) (OB-cadherin). We summarize the existing knowledge regarding the role of CDH2 and CDH11 during development and differentiation in vivo and in vitro. We also discuss engineering strategies to control stem cell fate decisions by fine-tuning the extent of cell–cell adhesion through surface chemistry and microtopology. These studies may be greatly facilitated by novel strategies that enable monitoring of stem cell specification in real time. We expect that better understanding of how intercellular adhesion signaling affects lineage specification may impact biomaterial and scaffold design to control stem cell fate decisions in three-dimensional context with potential implications for tissue engineering and regenerative medicine. © 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
    [Show full text]
  • In Prostate Cancer Tissues of Men with Type 2 Diabetes
    biomedicines Article Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate Cancer Tissues of Men with Type 2 Diabetes Andras Franko 1,2,3 , Lucia Berti 2,3 , Jörg Hennenlotter 4 , Steffen Rausch 4, Marcus O. Scharpf 5, Martin Hrabe˘ de Angelis 3,6, Arnulf Stenzl 4 , Andreas Peter 2,3,7, Andreas L. Birkenfeld 1,2,3, Stefan Z. Lutz 1,8, Hans-Ulrich Häring 1,2,3 and Martin Heni 1,2,3,7,* 1 Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, 72076 Tübingen, Germany; [email protected] (A.F.); [email protected] (A.L.B.); [email protected] (H.-U.H.) 2 Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, 72076 Tübingen, Germany; [email protected] 3 German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany 4 Department of Urology, University Hospital Tübingen, 72076 Tübingen, Germany; [email protected] (J.H.); steff[email protected] (S.R.); [email protected] (A.S.) 5 Institute of Pathology, University Hospital Tübingen, 72076 Tübingen, Germany; [email protected] 6 Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany; [email protected] 7 Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, 72076 Tübingen, Germany; [email protected] 8 Clinic for Geriatric and Orthopedic Rehabilitation Bad Sebastiansweiler, 72116 Mössingen, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-7071-29-82714 Received: 3 October 2020; Accepted: 12 November 2020; Published: 16 November 2020 Abstract: Type 2 diabetes (T2D) is associated with worse prognosis of prostate cancer (PCa).
    [Show full text]
  • N Cadherin (CDH2) Mouse Monoclonal Antibody [Clone ID: OTI3B10] Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA503775 N Cadherin (CDH2) Mouse Monoclonal Antibody [Clone ID: OTI3B10] Product data: Product Type: Primary Antibodies Clone Name: OTI3B10 Applications: FC, IHC, WB Recommend Dilution: WB 1:2000, IHC 1:150, FLOW 1:100 Reactivity: Human Host: Mouse Isotype: IgG2a Clonality: Monoclonal Immunogen: Full length human recombinant protein of human CDH2(NP_001783) produced in HEK293T cell. Formulation: PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. Concentration: 1 mg/ml Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) Predicted Protein Size: 97.2 kDa Gene Name: cadherin 2 Database Link: NP_001783 Entrez Gene 1000 Human Background: This gene is a classical cadherin from the cadherin superfamily. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. The protein functions during gastrulation and is required for establishment of left-right asymmetry. At certain central nervous system synapses, presynaptic to postsynaptic adhesion is mediated at least in part by this gene product. [provided by RefSeq] Synonyms: CD325; CDHN; CDw325; NCAD Protein Families: Druggable Genome, ES Cell Differentiation/IPS, Transmembrane Protein Pathways: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs) This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2020 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 N Cadherin (CDH2) Mouse Monoclonal Antibody [Clone ID: OTI3B10] – TA503775 Product images: HEK293T cells were transfected with the pCMV6- ENTRY control (Left lane) or pCMV6-ENTRY CDH2 ([RC207170], Right lane) cDNA for 48 hrs and lysed.
    [Show full text]
  • Epithelial-Mesenchymal Transition (EMT) Markers in Human Pituitary Adenomas Indicate a Clinical Course
    ANTICANCER RESEARCH 35: 2635-2644 (2015) Epithelial-mesenchymal Transition (EMT) Markers in Human Pituitary Adenomas Indicate a Clinical Course WANG JIA1,2,3 , JINKUI ZHU1,4, TRACEY A. MARTIN2,3,6, AIHUA JIANG5, ANDREW J. SANDERS2,3,6 and WEN G. JIANG2,3,6 1Department of Neurosurgery, Beijing TianTan Hospital, Capital Medical University, Beijing, P.R. China; 2Cancer and 3Brain Institutes, Capital Medical University-Cardiff University Joint Centre for Biomedical Research, Capital Medical University, Beijing, P.R. China; 4Department of Neurosurgery, Zhaoyuan City Hospital, YanTai, Shandong, P.R. China; 5Department of Anaesthesia, YuHuangDing Hospital, YanTai, P.R. China; 6CCMRC Cardiff University-Capital Medical University Joint Centre for Biomedical Research, Cardiff University School of Medicine, Heath Park, Cardiff, U.K. Abstract. Background/Aim: Pituitary adenomas are brain progression, bone destruction and endocrine functions. These tumors with invasive properties. Epithelial-mesenchymal- markers are valuable biomarkers in assessing the clinical transition (EMT) is a cellular process linked to the course of pituitary adenomas. transformation to an aggressive cancer phenotype. In the present study, we investigated the expression of a panel of Pituitary adenoma is a common benign tumor of the central EMT markers, namely E-cadherin, N-cadherin, SLUG, SNA1 nervous system with a number of biological behaviours and TWIST in a cohort of human pituitary adenomas. similar to malignant tumors, including invasion of the Materials and Methods: Fresh-frozen human pituitary tumors surrounding structures, such as the cavernous sinus, (n=95) were collected immediately after surgery for hypothalamus and sphenoid sinus, where it is named invasive histology. Gene transcripts of the EMT markers were adenoma (1).
    [Show full text]
  • Comprehensive Profiling of Novel Epithelial–Mesenchymal Transition
    www.nature.com/scientificreports OPEN Comprehensive profling of novel epithelial–mesenchymal transition mediators and their clinical signifcance in colorectal cancer Satoshi Ishikawa1, Naohiro Nishida1,2*, Shiki Fujino1, Takayuki Ogino1, Hidekazu Takahashi1, Norikatsu Miyoshi1, Mamoru Uemura1, Taroh Satoh1,2, Hirofumi Yamamoto1, Tsunekazu Mizushima1, Yuichiro Doki1 & Hidetoshi Eguchi1 Epithelial–mesenchymal transition (EMT) is a drastic phenotypic change during cancer metastasis and is one of the most important hallmarks of aggressive cancer. Although the overexpression of some specifc transcription factors explains the functional alteration of EMT-induced cells, a complete picture of this biological process is yet to be elucidated. To comprehensively profle EMT-related genes in colorectal cancer, we quantifed the EMT induction ability of each gene according to its similarity to the cancer stromal gene signature and termed it “mesenchymal score.” This bioinformatic approach successfully identifed 90 candidate EMT mediators, which are strongly predictive of survival in clinical samples. Among these candidates, we discovered that the neuronal gene ARC, possibly originating from the retrotransposon, unexpectedly plays a crucial role in EMT induction. Profling of novel EMT mediators we demonstrated here may help understand the complexity of the EMT program and open up new avenues for therapeutic intervention in colorectal cancer. Epithelial–mesenchymal transition (EMT) is a phenotypic change of epithelial cells, in which cells lose epithelial
    [Show full text]
  • Hsa Circ 001659 Serves As a Diagnostic and Prognostic Biomarker for Colorectal Cancer
    Hsa_circ_001659 serves as a diagnostic and prognostic biomarker for colorectal cancer Baoyu He Shanghai Jiao Tong University School of Medicine Aliated Renji Hospital Wei Chao Guangxi Medical University Zhizhuo Huang Guangxi Medical University Jianchao Zeng Guangxi medical university Jie Yang Guangxi medical university Delan Luo First Peoples Hospital of Neijiang Shishun Huang Guangxi medical university Hongli Pan ( [email protected] ) Guangxi medical university Yujun Hao Shanghai Jiao Tong University School of Medicine Aliated Renji Hospital Research Keywords: circular RNA, biomarker, early diagnosis, prognosis prediction, epithelial-mesenchymal transition, cytoskeleton, colorectal cancer Posted Date: December 29th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-135226/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/24 Abstract Background: Colorectal cancer (CRC) is prevalent worldwide and novel diagnostic and prognostic biomarkers are needed to improve precision medicine. Circulating circular RNAs (circRNAs) are currently being considered as emerging tumor biomarkers. Methods: Candidate circRNA was selected by integrating analysis of Gene Expression Omnibus (GEO) database using GEO2R program. The expression data of serum circ_001659 were obtained from the quantitative real-time polymerase chain reaction (qRT-PCR). Receiver operating characteristic curves were applied to evaluate the clinical applications of circ_001659. Finally, biological functions and potential mechanisms of circ_001659 in tumor progression were investigated in CRC progression. Results: The results showed that the diagnostic performance of serum circ_001659 were excellent for CRC detection. The predictive values and likelihood ratios were satisfactory for the diagnosis of CRC, including patients in early-stage disease or patients with carcinoembryonic antigen (CEA)-negative status.
    [Show full text]
  • The Art of Mast Cell Adhesion
    cells Review The Art of Mast Cell Adhesion Joanna Pastwi ´nska 1,2, Paulina Zelechowska˙ 2, Aurelia Walczak-Drzewiecka 1, Ewa Brzezi ´nska-Błaszczyk 2 and Jarosław Dastych 1,* 1 Laboratory of Cellular Immunology, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland; [email protected] (J.P.); [email protected] (A.W.-D.) 2 Department of Experimental Immunology, Medical University of Lodz, 92-213 Lodz, Poland; [email protected] (P.Z.);˙ [email protected] (E.B.-B.) * Correspondence: [email protected] Received: 30 October 2020; Accepted: 10 December 2020; Published: 11 December 2020 Abstract: Cell adhesion is one of the basic phenomena occurring in a living organism, affecting many other processes such as proliferation, differentiation, migration, or cell viability. Mast cells (MCs) are important elements involved in defending the host against various pathogens and regulating inflammatory processes. Due to numerous mediators, they are contributing to the modulation of many basic cellular processes in a variety of cells, including the expression and functioning of different adhesive molecules. They also express themselves many adhesive proteins, including ICAM-1, ICAM-3, VCAM-1, integrins, L-selectin, E-cadherin, and N-cadherin. These molecules enable MCs to interact with other cells and components of the extracellular matrix (ECM), creating structures such as adherens junctions and focal adhesion sites, and triggering a signaling cascade. A thorough understanding of these cellular mechanisms can create a better understanding of MC biology and reveal new goals for MC targeted therapy. This review will focus on the current knowledge of adhesion mechanisms with the involvement of MCs.
    [Show full text]